Literature DB >> 32337205

Pleural effusion in an immunocompetent host with cryptococcal pneumonia: A case report.

Huan-Huan Wu1, Yan-Xiao Chen2, Shuang-Yan Fang3.   

Abstract

BACKGROUND: Pulmonary cryptococcosis is an opportunistic infection that mainly occurs among immunocompromised patients although it can sometimes occur in immunocompetent individuals. However, the imaging findings of pulmonary cryptococcosis in immunocompetent hosts differ from those in immunosuppressed patients. In addition, the most common imaging findings of isolated pulmonary cryptococcosis are single or multiple nodules. Cavities and the halo sign are, however, prevalent in immunosuppressed patients. In immunocompetent patients, lung consolidation, pleural effusion or cavities are scarce. CASE
SUMMARY: A 29-year-old Asian male was admitted to our hospital with complaints of cough and fever that had persisted for a month. As a chest computed tomography scan showed consolidation in his left lower lobe, he was initially diagnosed with pneumonia and received antibiotic treatment. A second review of the chest computed tomography image revealed multiple cavities and pleural effusion. Flexible fiberoptic bronchoscopy was subsequently performed, bronchoalveolar lavage fluid and serum cryptococcal antigen tests were positive. Cryptococcus capsules were observed in bronchoalveolar lavage fluid ink stain. Histopathological examination of a percutaneous lung biopsy from the left lower lobe further revealed granulomatous inflammation, and periodic acid-Schiff staining showed red-colored yeast walls, signifying pulmonary cryptococcosis. The patient was then treated with a daily dose of fluconazole (0.4 g), but the cough and fever still persisted. We therefore changed treatment to voriconazole (0.2 g, twice a day), and the patient's clinical outcome was satisfactory.
CONCLUSION: Although rare, clinicians should not disregard the possibility of cavities and pleural effusion occurring in immunocompetent hosts without underlying diseases. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Case report; Computed tomography; Imaging findings; Immunocompetent; Pleural effusion; Pulmonary cryptococcosis

Year:  2020        PMID: 32337205      PMCID: PMC7176623          DOI: 10.12998/wjcc.v8.i7.1295

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  11 in total

1.  Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis.

Authors:  Yuan Zhang; Nan Li; Yuxuan Zhang; Huiping Li; Xueyuan Chen; Shanmei Wang; Xia Zhang; Rongxuan Zhang; Jinfu Xu; Jingyun Shi; Rex C Yung
Journal:  Eur Respir J       Date:  2012-03-09       Impact factor: 16.671

2.  An official American Thoracic Society statement: Treatment of fungal infections in adult pulmonary and critical care patients.

Authors:  Andrew H Limper; Kenneth S Knox; George A Sarosi; Neil M Ampel; John E Bennett; Antonino Catanzaro; Scott F Davies; William E Dismukes; Chadi A Hage; Kieren A Marr; Christopher H Mody; John R Perfect; David A Stevens
Journal:  Am J Respir Crit Care Med       Date:  2011-01-01       Impact factor: 21.405

3.  Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy.

Authors:  P G Pappas; J R Perfect; G A Cloud; R A Larsen; G A Pankey; D J Lancaster; H Henderson; C A Kauffman; D W Haas; M Saccente; R J Hamill; M S Holloway; R M Warren; W E Dismukes
Journal:  Clin Infect Dis       Date:  2001-07-26       Impact factor: 9.079

4.  Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis.

Authors:  Feng Ye; Jia-xing Xie; Qing-si Zeng; Guo-qin Chen; Shu-qing Zhong; Nan-shan Zhong
Journal:  Lung       Date:  2012-01-14       Impact factor: 2.584

5.  Pulmonary cryptococcosis in patients without HIV infection.

Authors:  J A Aberg; L M Mundy; W G Powderly
Journal:  Chest       Date:  1999-03       Impact factor: 9.410

6.  Clinical analysis of non-AIDS patients pathologically diagnosed with pulmonary cryptococcosis.

Authors:  Kaixiong Liu; Haibo Ding; Bing Xu; Ruixiong You; Zhen Xing; Jianfeng Chen; Qichang Lin; Jieming Qu
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

7.  Examination of cryptococcal glucuronoxylomannan antigen in bronchoalveolar lavage fluid for diagnosing pulmonary cryptococcosis in HIV-negative patients.

Authors:  Kazuhiro Oshima; Takahiro Takazono; Tomomi Saijo; Masato Tashiro; Shintaro Kurihara; Kazuko Yamamoto; Yoshifumi Imamura; Taiga Miyazaki; Misuzu Tsukamoto; Katsunori Yanagihara; Hiroshi Mukae; Shigeru Kohno; Koichi Izumikawa
Journal:  Med Mycol       Date:  2018-01-01       Impact factor: 4.076

Review 8.  A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.

Authors:  Felix Bongomin; Rita O Oladele; Sara Gago; Caroline B Moore; Malcolm D Richardson
Journal:  Mycoses       Date:  2018-02-14       Impact factor: 4.377

9.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

10.  Pulmonary Cryptococcosis in the Immunocompetent Patient-Many Questions, Some Answers.

Authors:  John F Fisher; Paula A Valencia-Rey; William B Davis
Journal:  Open Forum Infect Dis       Date:  2016-09-03       Impact factor: 3.835

View more
  1 in total

1.  Pleural involvement in cryptococcal infection.

Authors:  Vasiliki E Georgakopoulou; Christos Damaskos; Pagona Sklapani; Nikolaos Trakas; Aikaterini Gkoufa
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.